Home » CIPLA TO LAUNCH ARTHRITIS DRUG MOBIX IN INDIA
CIPLA TO LAUNCH ARTHRITIS DRUG MOBIX IN INDIA
Pharma major Cipla has launched "MOBIX" capsules and topical cream for treatment of osteoarthritis and rheumatoid arthritis under a technical collaboration with Cymbiotics of San Diego, USA. Mobix formulations contain a proprietary blend of cetylated fatty acid esters (complex) and have been clinically proven in several studies to be safe and effective in the treatment of joint pain and inflammation in arthritis.
Deepika Global (http://www.deepikaglobal.com/search_newsdetail.asp?newscode=87579)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct